| scholarly article | Q13442814 |
| P2093 | author name string | George A Truskey | |
| P2860 | cites work | Biofunctional hydrogels for skeletal muscle constructs. | Q53601560 |
| Obesity and insulin resistance in humans: a dose-response study. | Q54325234 | ||
| Antisense PMO cocktails effectively skip dystrophin exons 45-55 in myotubes transdifferentiated from DMD patient fibroblasts. | Q55284165 | ||
| The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization | Q70196543 | ||
| Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans | Q70231635 | ||
| Excitability and contractility of skeletal muscle engineered from primary cultures and cell lines | Q73512882 | ||
| Mechanical stimulation improves tissue-engineered human skeletal muscle | Q78354171 | ||
| Stem cell derived phenotypic human neuromuscular junction model for dose response evaluation of therapeutics | Q88081016 | ||
| A system to monitor statin-induced myopathy in individual engineered skeletal muscle myobundles | Q90970494 | ||
| Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture | Q24623940 | ||
| Toxic myopathies | Q27007256 | ||
| Optogenetic skeletal muscle-powered adaptive biological machines | Q27318519 | ||
| Microfluidic device for the formation of optically excitable, three-dimensional, compartmentalized motor units | Q27334752 | ||
| Molecular identification and characterisation of the human eag2 potassium channel | Q28215695 | ||
| Measurement of contractile stress generated by cultured rat muscle on silicon cantilevers for toxin detection and muscle performance enhancement | Q28474335 | ||
| Genomic responses in mouse models poorly mimic human inflammatory diseases | Q29547718 | ||
| Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals | Q30050310 | ||
| Microfabricated tissue gauges to measure and manipulate forces from 3D microtissues | Q30488399 | ||
| Engineered skeletal muscle tissue networks with controllable architecture | Q30489537 | ||
| Biohybrid thin films for measuring contractility in engineered cardiovascular muscle. | Q30493650 | ||
| Formation and optogenetic control of engineered 3D skeletal muscle bioactuators | Q30537019 | ||
| Hybrid hydrogels containing vertically aligned carbon nanotubes with anisotropic electrical conductivity for muscle myofiber fabrication | Q30574350 | ||
| Biomimetic engineered muscle with capacity for vascular integration and functional maturation in vivo | Q30576471 | ||
| Comparison of GLUT1, GLUT3, and GLUT4 mRNA and the subcellular distribution of their proteins in normal human muscle | Q30644031 | ||
| Drug-induced prolongation of the QT interval | Q33151147 | ||
| Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes | Q33556644 | ||
| Satellite cells and the muscle stem cell niche | Q33816665 | ||
| MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes | Q33843740 | ||
| A functional system for high-content screening of neuromuscular junctions in vitro | Q33882255 | ||
| Phototactic guidance of a tissue-engineered soft-robotic ray. | Q33926272 | ||
| A multiplexed chip-based assay system for investigating the functional development of human skeletal myotubes in vitro | Q34053670 | ||
| Roles of adherent myogenic cells and dynamic culture in engineered muscle function and maintenance of satellite cells | Q34146576 | ||
| Rapid determination of myosin heavy chain expression in rat, mouse, and human skeletal muscle using multicolor immunofluorescence analysis | Q34243643 | ||
| The role of extracellular matrix composition in structure and function of bioengineered skeletal muscle | Q34673333 | ||
| Correlation of embryonic skeletal muscle myotube physical characteristics with contractile force generation on an atomic force microscope-based bio-microelectromechanical systems device | Q34991730 | ||
| Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects | Q35768572 | ||
| Soluble miniagrin enhances contractile function of engineered skeletal muscle | Q35790235 | ||
| Endothelial Network Formation Within Human Tissue-Engineered Skeletal Muscle | Q42592508 | ||
| Bioengineered human myobundles mimic clinical responses of skeletal muscle to drugs | Q43159102 | ||
| Cerivastatin and reports of fatal rhabdomyolysis | Q43886363 | ||
| Skeletal muscle atrophy in bioengineered skeletal muscle: a new model system | Q44154187 | ||
| Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content. | Q44491912 | ||
| Contractility and kinetics of human fetal and human adult skeletal muscle. | Q45906713 | ||
| Effects of the rapid-acting insulin analog glulisine on cultured human skeletal muscle cells: comparisons with insulin and insulin-like growth factor I. | Q46022138 | ||
| Glucose concentration and streptomycin alter in vitro muscle function and metabolism. | Q46028501 | ||
| Skeletal muscle-on-a-chip: an in vitro model to evaluate tissue formation and injury. | Q46263611 | ||
| Contractile and metabolic properties of engineered skeletal muscle derived from slow and fast phenotype mouse muscle | Q46526576 | ||
| Microfluidic culture platform for neuroscience research | Q46771334 | ||
| Drug-screening platform based on the contractility of tissue-engineered muscle. | Q46781309 | ||
| Incomplete MyoD-induced transdifferentiation is associated with chromatin remodeling deficiencies | Q47111540 | ||
| Creation of disease-inspired biomaterial environments to mimic pathological events in early calcific aortic valve disease | Q47215469 | ||
| Organogenesis of skeletal muscle in tissue culture | Q47768913 | ||
| Quantitative, Label-Free Evaluation of Tissue-Engineered Skeletal Muscle Through Multiphoton Microscopy | Q47792369 | ||
| Efficient transdifferentiation of human dermal fibroblasts into skeletal muscle. | Q48336711 | ||
| Engineering human pluripotent stem cells into a functional skeletal muscle tissue | Q49165157 | ||
| The effect of chronic high insulin exposure upon metabolic and myogenic markers in C2C12 skeletal muscle cells and myotubes. | Q49562862 | ||
| Automated fabrication of photopatterned gelatin hydrogels for organ-on-chips applications | Q50027536 | ||
| Optically controlled contraction of photosensitive skeletal muscle cells | Q50436397 | ||
| Screening out irrelevant cell-based models of disease. | Q50479880 | ||
| Muscular thin films for building actuators and powering devices. | Q50917662 | ||
| Factors affecting the structure and maturation of human tissue engineered skeletal muscle. | Q51020505 | ||
| Functional evaluation of nerve-skeletal muscle constructs engineered in vitro. | Q51185520 | ||
| Cultured slow vs. fast skeletal muscle cells differ in physiology and responsiveness to stimulation. | Q51282170 | ||
| Excitability and isometric contractile properties of mammalian skeletal muscle constructs engineered in vitro. | Q52166108 | ||
| Three-Dimensional Human iPSC-Derived Artificial Skeletal Muscles Model Muscular Dystrophies and Enable Multilineage Tissue Engineering. | Q52317296 | ||
| Inflammatory but not mitogenic contexts prime synovial fibroblasts for compensatory signaling responses to p38 inhibition. | Q52671165 | ||
| Contractile properties of developing human fetal cardiac muscle. | Q52910400 | ||
| Neuromuscular Junction Formation in Tissue-Engineered Skeletal Muscle Augments Contractile Function and Improves Cytoskeletal Organization | Q36160903 | ||
| Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments | Q36322021 | ||
| Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy | Q36534906 | ||
| The denervated muscle: facts and hypotheses. A historical review | Q36560326 | ||
| Myotubes derived from human-induced pluripotent stem cells mirror in vivo insulin resistance | Q36607500 | ||
| Effects of Dexamethasone on Satellite Cells and Tissue Engineered Skeletal Muscle Units | Q36707672 | ||
| Design, evaluation, and application of engineered skeletal muscle | Q36768118 | ||
| Cell Density and Joint microRNA-133a and microRNA-696 Inhibition Enhance Differentiation and Contractile Function of Engineered Human Skeletal Muscle Tissues. | Q36825916 | ||
| Murine models of atrophy, cachexia, and sarcopenia in skeletal muscle | Q36941459 | ||
| Microfluidic heart on a chip for higher throughput pharmacological studies | Q37205939 | ||
| A human in vitro model of Duchenne muscular dystrophy muscle formation and contractility | Q37325795 | ||
| Mammalian animal models for Duchenne muscular dystrophy | Q37393140 | ||
| Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle. | Q37630442 | ||
| Fiber types in mammalian skeletal muscles | Q37947567 | ||
| Skeletal muscle degenerative diseases and strategies for therapeutic muscle repair | Q38057347 | ||
| Glucocorticoid-induced skeletal muscle atrophy | Q38117492 | ||
| Myasthenia gravis and the neuromuscular junction | Q38128965 | ||
| Duchenne and Becker muscular dystrophies. | Q38230979 | ||
| Biomaterials based strategies for skeletal muscle tissue engineering: existing technologies and future trends | Q38428238 | ||
| Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro | Q38748704 | ||
| A novel bioreactor for the generation of highly aligned 3D skeletal muscle-like constructs through orientation of fibrin via application of static strain. | Q38856898 | ||
| Role of contraction duration in inducing fast-to-slow contractile and metabolic protein and functional changes in engineered muscle. | Q38889200 | ||
| Streptomycin decreases the functional shift to a slow phenotype induced by electrical stimulation in engineered muscle | Q38946183 | ||
| Microfluidic devices for construction of contractile skeletal muscle microtissues | Q38969454 | ||
| Factors That Affect Tissue-Engineered Skeletal Muscle Function and Physiology | Q39003016 | ||
| Three-dimensional neuron-muscle constructs with neuromuscular junctions | Q39095115 | ||
| Making muscle: skeletal myogenesis in vivo and in vitro. | Q39386999 | ||
| Defined electrical stimulation emphasizing excitability for the development and testing of engineered skeletal muscle | Q39441664 | ||
| A novel bioreactor for stimulating skeletal muscle in vitro. | Q39790842 | ||
| Dynamic properties of mammalian skeletal muscles | Q39885507 | ||
| The influence of serum-free culture conditions on skeletal muscle differentiation in a tissue-engineered model. | Q40003601 | ||
| Morphology and ultrastructure of differentiating three-dimensional mammalian skeletal muscle in a collagen gel. | Q40141791 | ||
| Efficient direct conversion of human fibroblasts into myogenic lineage induced by co-transduction with MYCL and MYOD1. | Q40202485 | ||
| Apparent elastic modulus and hysteresis of skeletal muscle cells throughout differentiation | Q40704679 | ||
| Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin | Q41020809 | ||
| Interaction among Skeletal Muscle Metabolic Energy Systems during Intense Exercise | Q41298141 | ||
| Glucose uptake in human and animal muscle cells in culture | Q41745498 | ||
| Glucose transporter content and glucose uptake in skeletal muscle constructs engineered in vitro | Q42456061 | ||
| Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures | Q42480893 | ||
| Human, Tissue-Engineered, Skeletal Muscle Myobundles to Measure Oxygen Uptake and Assess Mitochondrial Toxicity | Q42507596 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 13 | |
| P304 | page(s) | 3061-3073 | |
| P577 | publication date | 2018-10-01 | |
| P1433 | published in | Lab on a Chip | Q3214277 |
| P1476 | title | Development and application of human skeletal muscle microphysiological systems | |
| P478 | volume | 18 |
Search more.